Longitudinal Decline in Electrochemical Skin Conductance Reflects Disease Progression in Multiple System Atrophy.

Saved in:
Bibliographic Details
Title: Longitudinal Decline in Electrochemical Skin Conductance Reflects Disease Progression in Multiple System Atrophy.
Authors: Bastos P; Department of Clinical Pharmacology and Neurosciences, Toulouse University Hospital, Toulouse, France.; French Clinical Research Network (F-CRIN) for Parkinson's Disease and Movement Disorders (NS-Park-F-CRIN), Toulouse, France.; Clinical Investigation Center CIC 1436, CHU de Toulouse, Toulouse, France., Kermorgant M; Clinical Investigation Center CIC 1436, CHU de Toulouse, Toulouse, France.; Neurology Department, French MSA Reference Center, Toulouse University Hospital, Toulouse, France.; ToNIC-Toulouse Neuro Imaging Center-INSERM-UMR 1214, Toulouse, France., Ory-Magne F; Department of Clinical Pharmacology and Neurosciences, Toulouse University Hospital, Toulouse, France.; Clinical Investigation Center CIC 1436, CHU de Toulouse, Toulouse, France.; Centre de référence constitutif des syndromes paranéoplasiques et encéphalites auto-immunes, CHU Toulouse, Toulouse, France., Leung C; Department of Clinical Pharmacology and Neurosciences, Toulouse University Hospital, Toulouse, France.; Clinical Investigation Center CIC 1436, CHU de Toulouse, Toulouse, France., Fabbri M; Department of Clinical Pharmacology and Neurosciences, Toulouse University Hospital, Toulouse, France.; French Clinical Research Network (F-CRIN) for Parkinson's Disease and Movement Disorders (NS-Park-F-CRIN), Toulouse, France.; Clinical Investigation Center CIC 1436, CHU de Toulouse, Toulouse, France.; Neurology Department, French MSA Reference Center, Toulouse University Hospital, Toulouse, France., Rascol O; Department of Clinical Pharmacology and Neurosciences, Toulouse University Hospital, Toulouse, France.; French Clinical Research Network (F-CRIN) for Parkinson's Disease and Movement Disorders (NS-Park-F-CRIN), Toulouse, France.; Clinical Investigation Center CIC 1436, CHU de Toulouse, Toulouse, France.; Neurology Department, French MSA Reference Center, Toulouse University Hospital, Toulouse, France., Foubert-Samier A; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, CRMR AMS, Bordeaux, France.; University of Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France., Bendetowicz D; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, CRMR AMS, Bordeaux, France.; University of Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France., Meissner WG; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, CRMR AMS, Bordeaux, France.; University of Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France.; Department of Medicine, University of Otago, Christchurch, New Zealand.; New Zealand Brain Research Institute, Christchurch, New Zealand., Pavy-le-Traon A; Clinical Investigation Center CIC 1436, CHU de Toulouse, Toulouse, France.; Neurology Department, French MSA Reference Center, Toulouse University Hospital, Toulouse, France.; ToNIC-Toulouse Neuro Imaging Center-INSERM-UMR 1214, Toulouse, France.
Source: European journal of neurology [Eur J Neurol] 2026 Jun; Vol. 33 (6), pp. e70620.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1468-1331
DOI:10.1111/ene.70620